ArticleClinical ophthalmology (Auckland, N.Z.)2025
Correlation of Blood Glucose Control With Cystoid Macular Edema and Central Macular Thickness After Cataract Surgery in Diabetics.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Defining a Cataract Surgery Protocol in Diabetic Patients: A Pilot Study.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Macular edema and retinal thickening after cataract surgery can lead to poor vision in patients, especially in the presence of high glucose. Blood glycosylated hemoglobin (HbA1c) concentration plays an important role in assessing diabetic control and is closely related to cataract surgery prognosis. The aim of this study was to investigate the correlation between postoperative HbA1c levels and postoperative cystoid macular edema (CME) and central macular thickness (CMT) in diabetic cataract patients. Methods: Retrospective analysis was conducted on 80 patients with diabetic cataracts from December 2018 to December 2023. The enrolled cases were divided into 2 groups according to the blood glucose control: 56 cases (56 eyes) in the intensive treatment group (HbA1c ≤ 7.0%) with insulin combined with oral hypoglycemic agents; and 24 cases (24 eyes) in the standard treatment group (HbA1c > 7.0%). The Student's Results: Patients who went through the standard treatment showed significant CMT thickening and CME at 3 and 6 months postoperatively. HbA1c levels were positively correlated with CME and CMT at 1, 3, and 6 months postoperatively, with good predictive efficacy. Conclusion: Postoperative HbA1c levels have a strong correlation with CME and CMT thickening and may be reliable and valid biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.